| Ytd | -51.83% | |
| 1y | -61.11% |
| Open | 5.33 | Prev Close | 5.33 | Low | 5.25 | High | 5.41 | Mkt Cap | 48.85M |
| Vol | 1.02K | Avg Vol | 6.97K | EPS | -1.19 | P/E | N/A | Forward P/E | N/A |
| Beta | 3.19 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-12 | 50-d Avg | 6.10 | 200-d Avg | 8.30 | 1yr Est | 0.00 |
Gainers EXoZymes (NASDAQ:EXOZ) stock increased by 7.5% to $7.18 during Wednesday's after-market
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday&#
Company to collaborate with Lawrence Berkeley National Laboratory on AI-enabled digital twins design
Award allows eXoZymes to expand its portfolio of proprietary new-to-nature molecules and potential f
eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes" or "Company") - a pioneer of AI-enhanced enz